Kerala Health Minister Orders Probe Into Expired Drug Use in Nipah Cases

The Kerala Health Department has ordered a comprehensive medical board inquiry following allegations that expired antiviral medication may have been used in treating Nipah patients, according to Health Minister K. Muraleedharan. The investigation will specifically examine whether the use of expired Remdesivir contributed to fatalities among Nipah virus cases recently reported in the state.

Remdesivir, an antiviral drug used in treating severe viral infections, is a critical component of Nipah virus treatment protocols. The potential use of expired stock raises serious questions about pharmaceutical supply chain management and patient safety protocols within Kerala's healthcare system.

Muraleedharan stated that the medical board will conduct a thorough examination of drug procurement procedures, storage conditions, and administration records at the facilities where Nipah patients were treated. The inquiry aims to establish whether expired medication contributed to adverse outcomes and to identify any systemic lapses in drug management.

Nipah virus, a zoonotic pathogen that spreads from animals to humans, has periodically emerged in Kerala over the past two decades. The virus carries a high mortality rate, and treatment outcomes depend heavily on early detection and appropriate medical intervention, making medication quality and efficacy paramount in patient care.